• Bismuth Subsalicylate GI Assay Workflows

  2026-09-08

  Build more interpretable gastrointestinal disorder research workflows with Bismuth Subsalicylate, combining prostaglandin-pathway experiments with orthogonal membrane-integrity and apoptosis measurements. The key advantage is not a claim of superior potency, but controlled handling of an insoluble bismuth salt and clear separation of compound exposure from downstream cell-state effects.

• TH287 MTH1 Inhibitor for Radiosensitization

  2026-09-08

  TH287 converts oxidized nucleotide stress into a tractable cancer-cell radiosensitization workflow. This bench guide translates schedule-dependent CRPC evidence into compound handling, assay design, mechanistic readouts, and troubleshooting decisions.

• PKH26 Red Fluorescent Cell Linker Kit Guide

  2026-09-07

  The PKH26 Red Fluorescent Cell Linker Kit labels cell membrane lipid regions with a stable red fluorescent signal for cell tracing and proliferation-oriented assays. It is intended for membrane labeling in vitro and in vivo, not for intracellular targets or non-membrane labeling, and experimental conditions should be optimized without assuming unprovided concentrations or incubation times.

• Griseofulvin Workflow for Microtubule Assays

  2026-09-07

  Griseofulvin is a DMSO-soluble microtubule associated inhibitor suited to fungal growth, mitotic phenotyping, and mechanism-focused assay development. This guide connects practical formulation and exposure controls with the tiered flow-cytometry strategy reported for distinguishing tubulin-driven aneugenic mechanisms.

• Nintedanib (BIBF 1120) Research Workflows

  2026-09-05

  Build reproducible Nintedanib assays around receptor biology, ATRX-aware glioma stratification, and orthogonal measures of apoptosis and angiogenesis. This guide distinguishes evidence-supported starting conditions from optimization choices for cancer, fibrosis, and translational model development.

• Recombinant Annexin V for Apoptosis Detection

  2026-09-04

  Brumatti, Sheridan, and Martin describe a practical bacterial-expression and purification workflow for polyhistidine-tagged recombinant annexin V, followed by FITC conjugation for detecting phosphatidylserine exposure. The study’s main contribution is a reproducible route to a soluble probe that supports flow-cytometric and microscopic analysis of apoptotic membrane changes.

• Broad-Spectrum Bivalent mRNA Vaccine: RQ3025 Study

  2026-09-04

  Lu and colleagues evaluated RQ3025, a bivalent mRNA vaccine designed around shared SARS-CoV-2 spike mutations, in several animal models. The vaccine generated broad neutralizing activity, protected vaccinated rats against emerging variants, induced a Th1-biased cellular response, and showed no histological toxicity in the reported high-dose rat assessment.

• 5-Aminolevulinic acid HCl in Infection Research

  2026-09-03

  5-Aminolevulinic acid HCl provides a practical way to perturb heme-pathway flux while separating bacterial metabolism from host-cell effects. This article translates Salmonella phagocytosis findings into assay workflows, controls, optimization steps, and carefully bounded cancer-research applications.

• Firefly Luciferase mRNA for Causal Assay Design

  2026-09-03

  Firefly Luciferase mRNA (ARCA, 5mCTP, ΨUTP) can function as more than a transfection control: it helps researchers distinguish delivery, translation, cellular energy, and assay-specific effects. This guide develops a mechanistic workflow informed by engineered mRNA delivery research and practical reporter-assay design.

• Erastin: From Ferroptosis Mechanism to Translation

  2026-09-02

  Erastin is more than a ferroptosis inducer: it is a mechanistic probe for testing how oncogenic context, iron handling, redox balance, and system Xc⁻ vulnerability converge in tumor cells. This thought-leadership guide connects recent iron- and ROS-dependent plant defense findings with practical experimental design and translational decision-making in cancer biology research.

• GSK2606414: Selective PERK Inhibitor Guide

  2026-09-02

  GSK2606414 is a potent PERK inhibitor with a reported biochemical IC50 of 0.4 nM and strong kinase-panel selectivity. It supports controlled ER stress research and helps connect PERK–eIF2α signaling with disease-model phenotypes, while requiring careful separation of compound evidence from genetic pathway evidence.

• WIP1/PPM1D, p38 MAPK, and Pyroptosis in AKI

  2026-09-01

  The reference study identifies WIP1/PPM1D as a phosphatase that restrains p38 MAPK-associated pyroptosis in sepsis-associated acute kidney injury. By combining single-cell data, human and mouse kidney analyses, and pharmacological inhibition in HK2 cells and mice, it connects PPM1D signaling pathway activity with renal tubular inflammatory cell death.

• (-)-Blebbistatin in Multimodal Cardiac Research

  2026-09-01

  A strategic framework for using (-)-Blebbistatin as a reversible non-muscle myosin II perturbation alongside transparent, stretchable cardiac bioelectronics. The approach links cytoskeletal mechanics with electrophysiology, metabolism, and translational disease modeling without confusing measurement with mechanism.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-08-31

  Build translation-ready, ARCA-capped and polyadenylated transcripts through one coordinated workflow for vaccine, translation, antisense, and RNAi studies. This practical guide connects bench-scale RNA quality control with the spleen-targeted neoantigen vaccine findings reported in hepatocellular carcinoma research.

• CDELNs Relieve Sertoli Cell Cycle Arrest

  2026-08-31

  The reference study reports that Cistanche deserticola exosome-like nanovesicles protect against cyclophosphamide-induced testicular injury by delivering miR159b-3p to Sertoli cells. The proposed mechanism links heparan sulfate proteoglycan-mediated uptake with suppression of P21 and phosphorylation-dependent CDK1 activation, while human single-cell data provide translational context.

7879 records 1/526 page Next 12345 下5页 Last page